Today's Price Stats 
Today's Price Summary (NSE) 
As of: 10:58 PM on 06-AugPerformance Today
Outperformed Sector by 1.59%
Consecutive Gain
Stock has been gaining for the last 3 days and has risen 12.28% returns in the period
Weighted Average Price
More Volume traded close to High Price
Moving Averages
Sudeep Pharma is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages
Rising Investor Participation
Delivery Vol of 5.24 lacs on 05 Aug has risen by 285.52% against 5-day avg delivery vol
Liquidity
Based on 2% of 5 day average traded Value the stock is liquid enough for trade size of Rs 1.03 cr
Moving Averages 
Delivery Volumes 
Trailing 1 Month: 05-Jul-26 To 05-Aug-26
Previous 1 Month: 04-Jun-26 To 04-Jul-26
1 Month
Delivery volume fell by 27.58%
1 Day
Delivery volume increased by 285.52% over 5 day average
Recent Bulk Deals
4-Aug-2026
Nuvama Crossover Opportunities Fund - Series Iii sold 6.14 lacs shares at INR 850 on NSE
4-Aug-2026
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio bought 11.76 lacs shares at INR 850 on NSE
24-Jul-2026
Sbi Mutual Fund bought 2 lacs shares at INR 800 on NSE
24-Jul-2026
Nuvama Crossover Opportunities Fund - Series Iiia sold 9.4 lacs shares at INR 800 on NSE
24-Jul-2026
Nuvama Crossover Opportunities Fund - Series Iii sold 10.6 lacs shares at INR 800 on NSE
Recent Block Deals
4-Aug-2026
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio bought 11.76 lacs shares at INR 850 on NSE
4-Aug-2026
Nuvama Crossover Opportunities Fund - Series Iii sold 6.14 lacs shares at INR 850 on NSE
4-Aug-2026
Nuvama Crossover Opportunities Fund - Series Iiia sold 5.62 lacs shares at INR 850 on NSE
24-Jul-2026
Nuvama Crossover Opportunities Fund - Series Iii sold 10.6 lacs shares at INR 800 on NSE
24-Jul-2026
Nuvama Crossover Opportunities Fund - Series Iiia sold 9.4 lacs shares at INR 800 on NSE






